Cardax, Inc. announced the appointment of George W. Bickerstaff, former CFO of Novartis Pharma AG, Tamar D. Howson, former senior business development executive at Bristol-Myers Squibb and SmithKline Beecham, and Terence A. Kelly, Ph.D., former senior Boehringer Ingelheim anti-inflammatory R&D executive and current CEO of CoMentis, as independent members of its board of directors. They will join current Executive Chairman Nicholas Mitsakos, independent director Frank Herringer, and Cardax CEO David G. Watumull on the Cardax board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2021 | Cardax, Inc. announced a financing transaction | CI |
2021 | Cardax, Inc. Announces Restructuring of Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 0 | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- CDXI Stock
- News Cardax, Inc.
- Cardax, Inc. Announces Board Appointments